Radical Revelations: The Interplay of Nitrosative Stress, the Endocannabinoid System, and Treatment of Age-Related Disorders.
New endocannabinoid system neurodegeneration research reveals complex interactions between cannabis compounds and brain inflammatory pathways. This review examines how ECS modulation may influence nitrosative stress in neurodegenerative diseases.…
Study Reveals Lung-Brain Link Between Smoking and Neurodegeneration
Understanding the lung-brain axis smoking neurodegeneration link is crucial for clinicians advising on cannabis consumption methods. This study highlights pulmonary inflammation's role in brain health. It supports harm reduction strategies favoring…
CBD Found to Reverse Brain Damage in Mouse Model of Alzheimer’s Disease
New CBD neuroprotection preclinical research suggests potential reversal of brain damage in Alzheimer's mouse models. This early evidence may guide future clinical trials and patient counseling. However, translation to human treatment remains uncertain.
Effects of Chronic Cannabidiol on Alzheimer’s Disease Brain Pathology
This study investigates cannabidiol Alzheimer disease neuroprotection in the tau P301s-line PS19 mouse model. Chronic cannabidiol administration showed potential to reduce brain pathology and behavioral deficits. These findings highlight early-stage…
Fecal Transplants and the Gut Microbiome in Early Parkinson’s Disease
Emerging research on gut microbiome Parkinsons disease suggests fecal transplants may improve motor symptoms in early Parkinson’s. This study supports the gut-brain axis role in neurodegeneration. Understanding this connection could lead to novel…
Alzheimer’s and Medical Cannabis: Utah Department of Health Guidelines
Utah's Alzheimer's disease cannabis guidelines provide a structured clinical framework for medical cannabis use in neurodegenerative care. These guidelines help clinicians navigate treatment of behavioral symptoms and neuroinflammation. They represent a…
Smoking Cannabis and Tobacco Linked to Brain Volume Loss
Recent research highlights cannabis tobacco brain volume loss as a significant neurological risk. Concurrent use may accelerate cognitive decline beyond addiction concerns. Clinicians should counsel patients on these combined effects for better…
Cell therapy eases Parkinson’s motor symptoms in early trial
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseCell…
Variations in p21 Protein May Explain Why Some MS Types Progress Faster
Emerging research on multiple sclerosis biomarkers highlights the role of p21 protein variations in disease progression. Understanding these biomarkers may help identify patients at higher risk for aggressive MS types. This insight supports the…
When it comes to Parkinson’s, hope is not a plan, but urgent action is
Parkinsons disease cannabis treatment requires urgent action rather than passive hope. Patients must understand the distinction between evidence-based therapies and unproven claims. This approach helps manage symptoms effectively while setting realistic…
